Reata Pharmaceuticals To Jump 220%? Plus JP Morgan Predicts $51 For Las Vegas Sands

  • Goldman Sachs boosted the price target on Reata Pharmaceuticals, Inc. RETA from $86 to $115. Goldman Sachs analyst Madhu Kumar maintained the stock with a Buy rating. Reata Pharmaceuticals shares rose 1.9% to close at $36.03 on Friday.
  • RBC Capital slashed the price target on Edwards Lifesciences Corporation EW from $118 to $105. Edwards Lifesciences shares gained 0.6% to close at $76.36 on Friday.
  • JP Morgan raised the price target on Las Vegas Sands Corp. LVS from $44 to $51. Las Vegas Sands shares rose 3.9% to $44.85 in pre-market trading.
  • JP Morgan boosted the price target on First Solar, Inc. FSLR from $147 to $190. First Solar shares fell 2.9% to $166.51 in pre-market trading.
  • Needham cut the price target for Petco Health and Wellness Company, Inc. WOOF from $30 to $20. Petco Health and Wellness shares rose 1.9% to $10.09 in pre-market trading

Check out this: Goldman Sachs, Walmart And These 2 Stocks Insiders Are Selling

Market News and Data brought to you by Benzinga APIs
Price Target
Posted In: NewsPrice TargetSmall CapMarketsAnalyst RatingsTrading IdeasCasinos & GamingConsumer DiscretionaryPT Changes
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!